Volume 16, Issue 4 pp. 688-697

Relationship between asthma control status, the Asthma Control Test™ and urgent health-care utilization in Asia

CHRISTOPHER K.W. LAI

Corresponding Author

CHRISTOPHER K.W. LAI

The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Christopher K. W. Lai, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, c/o Room 1403, Takshing House, 20 Des Voeux Road Central, Hong Kong. Email: [email protected]Search for more papers by this author
FANNY W.S. KO

FANNY W.S. KO

The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Search for more papers by this author
ARVIND BHOME

ARVIND BHOME

Aditya Birla Memorial Hospital and Research Center, Pune, India

Search for more papers by this author
TERESITA S. DE GUIA

TERESITA S. DE GUIA

the Philippine Heart Center, Quezon City, The Philippines

Search for more papers by this author
GARY W.K. WONG

GARY W.K. WONG

The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Search for more papers by this author
BIN M.Z. ZAINUDIN

BIN M.Z. ZAINUDIN

Damansara Specialist Hospital, Petaling Jaya, Malaysia

Search for more papers by this author
AN N. NANG

AN N. NANG

the Institute of Asthma and Allergy

Search for more papers by this author
WATCHARA BOONSAWAT

WATCHARA BOONSAWAT

Khon Kaen University, Khon Kaen, Thailand

Search for more papers by this author
SANG H. CHO

SANG H. CHO

Seoul National University Hospital, Seoul, Korea

Search for more papers by this author
KIRTHI D. GUNASEKERA

KIRTHI D. GUNASEKERA

the Central Chest Clinic, Colombo, Sri Lanka

Search for more papers by this author
JIAN G. HONG

JIAN G. HONG

Shanghai no. 1 People's Hospital, Shanghai Jiaotong University, Shanghai, China

Search for more papers by this author
JENG-YUAN HSU

JENG-YUAN HSU

Taichung Veterans General Hospital, Taichung, Taiwan

Search for more papers by this author
NHUNG N. VIET

NHUNG N. VIET

National Hospital of Tuberculosis and Respiratory Diseases, Hanoi, Vietnam

Search for more papers by this author
FAISAL YUNUS

FAISAL YUNUS

the University of Indonesia, Persahabatan Hospital, Jakarta, Indonesia

Search for more papers by this author
AMARTYA MUKHOPADHYAY

AMARTYA MUKHOPADHYAY

National University Hospital, Singapore

Search for more papers by this author
First published: 01 March 2011
Citations: 37

Conflict of interest statement: This study was funded by GlaxoSmithKline (GSK). All authors except F. Ko received travel grants from GSK to attend AIRIAP 2 Steering Committee meetings. N. N. An, J. G. Hong, J.-Y. Hsu, A. Mukhopadhyay, V. H. Nhung, F. Yunus and F. Ko have nothing further to declare. C. K. W. Lai acts as an adviser for GSK and has received lecture fees and travel grants from AstraZeneca and GSK. A. Bhome owns 20 shares in GSK India. T. de Guia has received research grants, lecture fees and travel grants from AstraZeneca, Boehringer Ingelheim, GSK, Sanofi-Aventis and United Laboratories. G. W. K. Wong has received lecture fees and travel grants from AstraZeneca, GSK and Merck Sharp & Dohme (MSD). B. M. Z. Zainudin has received lecture fees from AstraZeneca and travel grants from GSK. W. Boonsawat has received lecture fees from AstraZeneca and GSK. S. H. Cho has received lecture fees and travel grants from GSK, AstraZeneca and MSD. K. D. Gunasekera has been a co-ordinator on a voluntary basis for the GSK-sponsored ISAAC study.

ABSTRACT

Background and objective:  Accurate assessment of control is an integral part of asthma management. We investigated the relationship between control status derived from the Global Initiative for Asthma (GINA), the Asthma Control Test (ACT) and urgent health-care utilization.

Methods:  Asthma Insights and Reality in Asia-Pacific Phase 2 (AIRIAP 2) was a cross-sectional, community-based survey of 4805 subjects with asthma from urban centres across Asia. A symptom control index was derived from the AIRIAP 2 questionnaire using the GINA control criteria for day- and night-time symptoms, need for rescue medication, activity limitation and exacerbations; lung function was excluded. The main outcomes were asthma control, based on these GINA criteria and the ACT, and the relationship between control and self-reported urgent health-care utilization (hospitalization, emergency room visits or other unscheduled urgent visits) related to asthma over the previous 12 months.

Results:  Each of the symptom criteria was significantly associated with urgent health-care utilization, with odds ratios (ORs) ranging from 2.25 (95% confidence interval (CI): 1.94–2.61) for daytime symptoms to 2.57 (95% CI: 2.29–2.90) for nocturnal awakening. Similarly, control status was significantly associated with urgent health-care utilization, with ORs of 0.19 (95% CI: 0.13–0.28), 0.70 (95% CI: 0.65–0.76) and 1.00 for controlled, partly controlled and uncontrolled, respectively. The optimal ACT cut-off score for identifying uncontrolled asthma was ≤19 for subjects aged ≥12 years. Urgent health-care utilization was reported by 57.2% versus 28.7% of patients scoring ≤19 versus >19 (P < 0.001).

Conclusions:  The GINA control classification and the ACT are valid symptom-based measures that are significantly associated with urgent health-care utilization.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.